30 Day Trial

Stryker Reports 2015 Revenue

Share:

Stryker reported 2015 orthopaedic revenue of US $4.2BB, +6.7% from 2014 in constant currency, and spine revenue of $740MM, +3.2%.

Stryker reported overall 2015 revenue of US $9.9BB, +7% from 2014 in constant currency. This includes non-orthopaedic product sales:

  • Orthopaedics $4,223MM, +6.7%
    • Knees $1,403MM, +4.6%
    • Hips $1,263MM, +3.1%
    • Trauma/Extremities $1,291MM, +10.8%
    • Other $266MM, +16.4%
  • MedSurg $3,895MM, +6.2%
  • Neurotechnology $1,088MM, +14.2%
  • Spine $740MM, +3.2%

 

Source: Stryker Corp.

 

ORTHOWORLD estimates 2015 segment sales and growth on an as-reported basis, as follows.

  • Joint Reconstruction $3,245.2MM, +3.3%
  • Trauma $1,194.4MM, +5.1%
  • Arthroscopy/Soft Tissue Repair $430.0MM, +0.5%
  • Spine $700.3MM, -0.1%
  • Orthobiologics $198.8MM, +1.4%